It is going to be a short amount of time before the fighter competes again, as Gouti has accepted a six month suspension from the United States Anti-Doping Agency (USADA). Gouti is going to be able to compete again on October 25 of this year since his suspension is retroactive to the date the provisional suspension began, which was April 25 of 2019.
USADA issued the following press release on the matter:
August 27, 2019
USADA announced today that Thibault Gouti, of Albuquerque, N.M., has accepted a six-month sanction for a violation of the UFC Anti-Doping Policy after testing positive for prohibited substances from a supplement.
Gouti, 32, tested positive for ostarine, LGD-4033 and its metabolite di-hydroxy-LGD-4033, and GW1516 metabolites GW1516 sulfoxide and GW1516 sulfone as the result of an out-of-competition urine sample he provided on March 12, 2019. LGD-4033 and ostarine are non-Specified Substances in the class of Anabolic Agents, while GW1516 is a non-Specified Substance in the category of Hormone and Metabolic Modulators. All of these substances are prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency (WADA) Prohibited List.
Following notification of his positive test, Gouti provided USADA with information about a dietary supplement product he used for two days before returning it to the store when he realized that ostarine was listed on the label. Subsequent analysis conducted on both the open and independently sourced, unopened containers of the product by the WADA-accredited laboratory in Salt Lake City, Utah, indicated that the product also contained LGD-4033 and GW1516, which were not listed on the label.
The product has since been added to the list of high-risk supplements maintained on USADA’s online dietary supplement safety education and awareness resource – Supplement 411 (www.Supplement411.org).
Gouti received a reduction from the otherwise applicable period of ineligibility due to his return of the supplement shortly after purchase and his substantial assistance. Gouti’s six-month period of ineligibility began on April 25, 2019, the date his provisional suspension was imposed.
USADA conducts the year-round, independent anti-doping program for all UFC athletes. USADA is an independent, non-profit, non-governmental agency whose sole mission is to preserve the integrity of competition, inspire true sport, and protect the rights of clean athletes. In an effort to aid UFC athletes, as well as their support team members, in understanding the rules applicable to them, USADA provides comprehensive instruction on the UFC Anti-Doping Program website (https://UFC.USADA.org) regarding the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements, as well as performance-enhancing and recreational drugs.
In addition, the agency manages a drug reference hotline, Drug Reference Online (https://UFC.GlobalDRO.com), conducts educational sessions, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, and periodic athlete alerts. Many of the resources available to athletes are provided in multiple languages, including Russian, Spanish, French, Portuguese, Korean, and Japanese.
Along with education and testing, robust anti-doping programs enable investigations stemming from tips and whistleblowers. USADA makes available a number of ways to report the abuse of performance-enhancing drugs in sport in an effort to protect clean athletes and promote clean competition. Any tip can be reported using the USADA Play Clean Tip Center, by email at playclean @usada.org, by phone at 1 877-Play Clean (1-877-752-9253), or by mail.